Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
The Lancet. Haematology|July 30, 2026
Haematopoietic cell transplantation for relapsed or refractory classical Hodgkin lymphoma: a retrospective, registry-based cohort study of 19 498 patients from the EBMT Lymphoma Working GroupAli Bazarbachi, Mathilde Fekom, Carmen Martinez, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 24, 2014
Fibrin glue therapy for severe hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantationMaria Cristina Tirindelli, Gerardo Paolo Flammia, Pierluigi Bove, et al.
Haematologica|November 12, 2009
Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO studyEmilio Paolo Alessandrino, Matteo Giovanni Della Porta, Andrea Bacigalupo, et al.
Bone Marrow Transplantation|August 19, 2025
Post-transplantation cyclophosphamide and antithymocyte globulin in 8/10 HLA-mismatched unrelated donor transplantation: the analysis on behalf of the transplant complications working party of the EBMTIvan Moiseev, Mouad Abouqateb, Christophe Peczynski, et al.
Cancers|April 3, 2021
Use of Measurable Residual Disease to Evolve Transplant Policy in Acute Myeloid Leukemia: A 20-Year Monocentric ObservationFrancesco Buccisano, Raffaele Palmieri, Alfonso Piciocchi, et al.
Transplantation and Cellular Therapy|June 20, 2025
Long-Term Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: An Italian Multicenter Collaborative StudyCorrado Tarella, Simona Sammassimo, Samuele Frassoni, et al.
American Journal of Hematology|April 23, 2013
Optimal timing of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndromeEmilio Paolo Alessandrino, Matteo G Della Porta, Luca Malcovati, et al.
Blood|February 22, 2014
Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-RMatteo G Della Porta, Emilio Paolo Alessandrino, Andrea Bacigalupo, et al.
Transplantation|December 4, 2020
Veno-occlusive Disease in HSCT Patients: Consensus-based Recommendations for Risk Assessment, Diagnosis, and Management by the GITMO GroupFrancesca Bonifazi, Simona Sica, Alessia Angeletti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 19, 2020
Matched-Pair Analysis of Transplant from Haploidentical, Unmanipulated Bone Marrow Donor versus HLA Identical Sibling for Patients with Hematologic MalignanciesWilliam Arcese, Raffaella Cerretti, Loredana Sarmati, et al.
Pageof 5